- Report
- May 2026
- 150 Pages
Malaysia
From €4373EUR$4,850USD£3,793GBP
- Report
- May 2026
- 150 Pages
Mexico
From €4373EUR$4,850USD£3,793GBP
- Report
- May 2026
- 150 Pages
Netherlands
From €4373EUR$4,850USD£3,793GBP
- Report
- May 2026
- 150 Pages
China
From €4373EUR$4,850USD£3,793GBP
- Report
- May 2026
- 150 Pages
Saudi Arabia
From €4373EUR$4,850USD£3,793GBP
- Report
- May 2026
- 150 Pages
South Africa
From €4373EUR$4,850USD£3,793GBP
- Report
- May 2026
- 150 Pages
South Korea
From €4373EUR$4,850USD£3,793GBP
- Report
- May 2026
- 150 Pages
Spain
From €4373EUR$4,850USD£3,793GBP
- Report
- May 2026
- 150 Pages
Thailand
From €4373EUR$4,850USD£3,793GBP
- Report
- May 2026
- 150 Pages
Turkey
From €4373EUR$4,850USD£3,793GBP
- Report
- May 2026
- 150 Pages
United Kingdom
From €4373EUR$4,850USD£3,793GBP
- Report
- March 2026
- 381 Pages
China
From €4373EUR$4,850USD£3,793GBP
- Report
- March 2026
- 170 Pages
Germany
From €4373EUR$4,850USD£3,793GBP
- Report
- March 2026
- 209 Pages
India
From €4373EUR$4,850USD£3,793GBP
- Report
- March 2026
- 342 Pages
Canada
From €4373EUR$4,850USD£3,793GBP
- Report
- May 2025
- 150 Pages
Global
From €4373EUR$4,850USD£3,793GBP
- Report
- January 2024
- 150 Pages
Global
From €4373EUR$4,850USD£3,793GBP
- Report
- July 2023
- 124 Pages
Asia Pacific
From €1353EUR$1,500USD£1,173GBP
- Report
- July 2023
- 124 Pages
Europe
From €1353EUR$1,500USD£1,173GBP
- Report
- July 2023
- 115 Pages
North America
From €1353EUR$1,500USD£1,173GBP

The Inhalers and Nebulisers market is a segment of the medical device industry that focuses on the development and production of devices used to deliver medication to the lungs. Inhalers and nebulisers are used to treat a variety of respiratory conditions, including asthma, COPD, and cystic fibrosis. Inhalers are handheld devices that deliver medication directly to the lungs in the form of a mist or aerosol. Nebulisers are larger devices that use a compressor to convert liquid medication into a mist that can be inhaled.
Inhalers and nebulisers are used by millions of people around the world, and the market is expected to grow in the coming years. Companies in the market include GlaxoSmithKline, Boehringer Ingelheim, AstraZeneca, Novartis, and Teva Pharmaceuticals. These companies are involved in the development and production of inhalers and nebulisers, as well as the research and development of new treatments for respiratory conditions. Show Less Read more